Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy

PURPOSE: The aim of this study was to determine whether the ERCC1 expression is effective to predict the clinical outcomes of patients with advanced gastric cancer (AGC) and who were treated with cisplatin-based first-line chemotherapy. MATERIALS AND METHODS: A total of 89 measurable AGC patients re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yun, Jina, Kim, Kyoung-Mee, Kim, Seung Tae, Kim, Jung-Hoon, Kim, Jung A, Kong, Jee Hyun, Lee, Soo Hyeon, Won, Young-Woong, Sun, Jong-Mu, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2901085/
https://ncbi.nlm.nih.gov/pubmed/20622964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.2.101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados